All News #Library
Biotech
Spero Announces Q4 and Full Year 2025 Operating Results
26 Mar 2026 //
GLOBENEWSWIRE
Spero Therapeutics To Release 2025 Q4 Financial Results
18 Mar 2026 //
GLOBENEWSWIRE
Former Spero Execs Fined By SEC Over Antibiotic Efficacy Claims
20 Jan 2026 //
FIERCE BIOTECH
GSK Resubmits Tebipenem HBr NDA To FDA For Complicated UTIs
19 Dec 2025 //
GLOBENEWSWIRE
Spero Therapeutics Grants Inducement Under Nasdaq Rule 5635(c)(4)
28 Nov 2025 //
GLOBENEWSWIRE
Ph3 PIVOT-PO Data Show Tebipenem HBr as First Oral Carbapenem
21 Oct 2025 //
GLOBENEWSWIRE
Spero Therapeutics Reveals Q2 2025 Results and Business Update
12 Aug 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support